Alteron Therapeutic is pharmaceutical startup dedicated to developing innovative drugs for the treatment Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We target high TDP-43 activity, which is the root cause of neuronal death.  By inhibiting TDP-43, out drugs can simultaneously eliminate the three pathological markers ofneurodegeneration and their efficacy has been verified in an hTDP-43 transgenic mouse disease model.

Biotechnology

Alteron Therapeutics

Alteron Therapeutics' headquarters in Kalamazoo, MI, United States

Description

People (0)

Jobs (0)

Other offices